Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128069) titled 'Can Vitamin D Reduce the Burden of COVID-19?' on Aug. 15. Study Type: Interve... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136103) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenic... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136116) titled 'Study to Assess Change in Disease Activity of Risankizumab Treatment in Japane... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136428) titled 'Asciminib in HER2+ Breast Cancer Brain Metastases' on Aug. 15. Study Type: In... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137312) titled 'Ex Vivo Expansion (ACT-X)' on Aug. 15. Study Type: Observational Primary Sp... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137767) titled 'Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Cro... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137819) titled 'Phase 3 - Evaluation of Veregen(R) 10% Ointment as New Herbal Topical Treatmen... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137910) titled 'A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participan... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137962) titled 'Pericapsular Nerve Group Block vs. Fascia Iliaca Compartment Block vs. Caudal ... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07138014) titled 'FHND1002 for ALS Treatment: Phase 2' on Aug. 15. Study Type: Interventional ... Read More